Evidence map›Paper›PMID 32821984›Full record

ArticlePsychopharmacology2020

Noradrenergic circuits in the forebrain control affective responses to novelty.

Daniel Lustberg, Rachel P Tillage, Yu Bai, Molly Pruitt, L Cameron Liles, David Weinshenker

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The development of compulsive coping behaviour is associated with a downregulation of Arc in a Locus Coeruleus neuronal ensemble.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniel LustbergDepartment of Human Genetics, Emory University, Atlanta, GA, 30322, USA.
Rachel P TillageDepartment of Human Genetics, Emory University, Atlanta, GA, 30322, USA.
Yu BaiDepartment of Human Genetics, Emory University, Atlanta, GA, 30322, USA.
Molly PruittUniversity of Maryland School of Medicine, Baltimore, MD, 21201, USA.
L Cameron LilesDepartment of Human Genetics, Emory University, Atlanta, GA, 30322, USA.
David WeinshenkerDepartment of Human Genetics, Emory University, Atlanta, GA, 30322, USA. dweinsh@emory.edu.
Emory University · USUniversity of Maryland, Baltimore · US

Funding

Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Training In Systems And Integrative Biology NeuroscienceT32NS096050 · NINDS · EMORY UNIVERSITY · PI Yoland Smith · 2016 to 2026
$3.9M
Mechanisms underlying selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG061175 · NIA · EMORY UNIVERSITY · PI KANG, SEONG SU, WEINSHENKER, DAVID · 2019 to 2019
$2.8M
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition 5R01DA038453-02 Diversity SupplementR01DA038453 · NIDA · EMORY UNIVERSITY · PI PALADINI, CARLOS ANTONIO, WEINSHENKER, DAVID · 2015 to 2019
$1.8M
Norepinephrine-dopamine interactions underlying arousalR01NS102306 · NINDS · EMORY UNIVERSITY · PI MITRANO, DARLENE A, WEINSHENKER, DAVID · 2017 to 2021
$1.8M
The role of locus coeruleus hyperactivity and galanin in depressive behaviorF31MH116622 · NIMH · EMORY UNIVERSITY · PI TILLAGE, RACHEL CATHERINE PEARCY · 2018 to 2020
$135k
NIA NIH HHS AG061175NIA NIH HHS RF1 AG061175NIDA NIH HHS DA038453NIDA NIH HHS R01 DA038453NIGMS NIH HHS GM8602-22NIGMS NIH HHS T32 GM008602NIMH NIH HHS F31 MH116622NIMH NIH HHS MH116622NINDS NIH HHS NS102306NINDS NIH HHS R01 NS102306NINDS NIH HHS T32 NS096050
6 · The paper itself

Abstract

rationaleIn rodents, exposure to novel environments elicits initial anxiety-like behavior (neophobia) followed by intense exploration (neophilia) that gradually subsides as the environment becomes familiar. Thus, innate novelty-induced behaviors are useful indices of anxiety and motivation in animal models of psychiatric disease. Noradrenergic neurons are activated by novelty and implicated in exploratory and anxiety-like responses, but the role of norepinephrine (NE) in neophobia has not been clearly delineated.

objectiveWe sought to define the role of central NE transmission in neophilic and neophobic behaviors.

methodsWe assessed dopamine β-hydroxylase knockout (Dbh -/-) mice lacking NE and their NE-competent (Dbh +/-) littermate controls in neophilic (novelty-induced locomotion; NIL) and neophobic (novelty-suppressed feeding; NSF) behavioral tests with subsequent quantification of brain-wide c-fos induction. We complimented the gene knockout approach with pharmacological interventions.

resultsDbh -/- mice exhibited blunted locomotor responses in the NIL task and completely lacked neophobia in the NSF test. Neophobia was rescued in Dbh -/- mice by acute pharmacological restoration of central NE with the synthetic precursor L-3,4-dihydroxyphenylserine (DOPS), and attenuated in control mice by the inhibitory α2-adrenergic autoreceptor agonist guanfacine. Following either NSF or NIL, Dbh -/- mice demonstrated reduced c-fos in the anterior cingulate cortex, medial septum, ventral hippocampus, bed nucleus of the stria terminalis, and basolateral amygdala.

conclusionThese findings indicate that central NE signaling is required for the expression of both neophilic and neophobic behaviors. Further, we describe a putative noradrenergic novelty network as a potential therapeutic target for treating anxiety and substance abuse disorders.

Indexed as

Adrenergic AgonistsAdrenergic alpha-2 Receptor AgonistsAdrenergic NeuronsAnimalsDopamine beta-HydroxylaseExploratory BehaviorFemaleLocomotionMaleMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutNerve NetNorepinephrineProsencephalonAdrenergic AgonistsAdrenergic alpha-2 Receptor AgonistsDopamine beta-HydroxylaseNorepinephrineAnxietyC-fosDopamine β-hydroxylaseGuanfacineLocus coeruleusNeophiliaNeophobiaNorepinephrineNovel environmentNovelty suppressed feeding

Identifiers

PMID32821984
PMCPMC7572912
OpenAlexW3081307838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.